A Day Up For Cyclacel Pharmaceuticals, Inc.
Tue, Jul 19, 2022 at 07:09 PM
Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ) soared at $1.52, representing a gain of 20.6%. On Tue, Jul 19, 2022, CYCC:NASDAQ touched a New 2-Week High of $1.52. The stock appeared on our News Catalysts scanner on Thu, Jun 30, 2022 at 10:24 AM in the 'BIOTECH' category. From Tue, Jul 05, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days
About Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ)
Cyclacel Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders, with development operations in US and UK.
Top 10 Gainers:
- Liquidia Technologies, Inc. (LQDA:NASDAQ), 45.31%
- Sidus Space Inc. (SIDU:NASDAQ), 40.64%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 32.17%
- Eos Energy Enterprises Inc. (EOSE:NASDAQ), 27.4%
- Power REIT (PW:NYSEMKT), 26.86%
- Verve Therapeutics Inc. (VERV:NASDAQ), 22.73%
- Fuwei Films (Holdings) Co., Ltd. (FFHL:NASDAQ), 22.59%
- Silvergate Capital Corporation (SI:NYSE), 22.37%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 20.63%
- DermTech, Inc. (DMTK:NASDAQ), 20.41%